Lots of great economy- and life-changing companies are in the mining and resource industries in this country, but not necessarily all.
Vancouver-based NeutriSci International Inc. (TSX-Venture:NU), which develops products for the nutraceutical industry, announced that Cryopharm Corp., its U.S. manufacturing and distribution partner, will start distribution of NeutriSci and Cryopharm's CBD & THC products into more than 90 dispensaries across Southern California the last week of August. The distribution is expected to grow to over 350 dispensaries in this year’s first quarter.
Wednesday’s news release read thus: "NeutriSci's Zenstix and Kushtabs, quick melting tabs activate faster when compared to other cannabis edibles, with a powerful and maximum allowable 10mg dose. Each stick contains (six) tablets in a child-resistant package."
Cryopharm's Marbl Melts™ represent an industry-first cannabis infused product; flavorful, micro dosed, rapidly dissolvable oral melts infused with THC & CBD. NeutriSci's core ingredients form the basis of Marbl Melts™, containing a clinically tested dosage providing on-set in as little as 12 minutes; compared to traditional cannabinoid infusion methods that often have incorrect dosages that can potentially take up to two hours to become active.
CEO Glen Rehman says, "Despite limited and reduced accessibility due to COVID-19, the California manufacturing facility has been able to gradually increase its production capacity to meet initial demands. Cryopharm has also been able to work with its network of distributors to secure initial orders and begin the distribution of the Zenstix and Kushtabs into Northern California as early as August 27."
NU shares grabbed a penny, or 7.1%, to 14.5 cents, on volume topping 518,000 shares.
